Source: Annual Congress 2010 - COPD: treatment and monitoring
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Müllerova, V. Pinto-Plata, C. Casanova, J. P. de Torres, H. Corado, N. Varo, E. Cordoba, S. Zeineldine, F. Cortopassi, B. Celli (Uxbridge, United Kingdom; Boston, United States Of America; Santa Cruz de Tenerife, Pamplona, Spain). Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile. Eur Respir J 2010; 36: Suppl. 54, 1336

Member's Comments

No comment yet.

Related content which might interest you: A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 The expression of selected biomarkers at the systemic and local level in patients with COPD Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018 Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Candidate surrogate markers for COPD identified by differential gene expression Source: Eur Respir J 2002; 20: Suppl. 38, 583s Year: 2002 Identification of clinical phenotypes using cluster analyses in COPD patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Changes in gene expression associated with COPD revealed by low density microarray analysis Source: Eur Respir J 2006; 28: Suppl. 50, 584s Year: 2006 Gene expression profiles of idiopathic interstitial pneumonias: Identification of disease-specific diagnostic markers and molecular therapeutic targets Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes Source: ERS Lung Science Conference 2016 Year: 2016 Microarray gene expression profiles in lung tissue of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 537s Year: 2007 Expression of apoptotic markers in lung tissue of COPD patients: preliminary results Source: Eur Respir J 2006; 28: Suppl. 50, 748s Year: 2006 Integrated analysis of COPD gene expression data reveals specific pathway signatures Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Evaluation of mRNA expression profiling of NF-?B mediated signaling in COPD patients. Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Gene expression profiling of induced sputum from COPD patients and healthy smokers Source: Eur Respir J 2006; 28: Suppl. 50, 746s Year: 2006 Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017